BRIEF published on 03/11/2024 at 16:07, 2 years 7 months ago Vanguard annonce une augmentation de sa participation dans Ageas SA/NV Marchés Financiers Acquisition D'actions Groupe D'avant-garde Ageas SA/NV Secteur Des Assurances
BRIEF published on 03/11/2024 at 16:07, 2 years 7 months ago Vanguard Reports Increased Stake in Ageas SA/NV Vanguard Group Financial Markets Stock Acquisition Ageas SA/NV Insurance Sector
PRESS RELEASE published on 03/11/2024 at 16:02, 2 years 7 months ago Form 8.3 - The Vanguard Group, Inc.: Ageas SA/NV The Vanguard Group, Inc. discloses 3.44% ownership of Ageas SA/NV's ordinary shares in Form 8.3 filing on 11th March 2024 Form 8.3 The Vanguard Group Inc. Ownership Disclosure Financial Securities Ageas SA/NV
BRIEF published on 03/08/2024 at 16:41, 2 years 7 months ago The Vanguard Group, Inc. annonce une position dans Ageas SA/NV Divulgation Financière Le Groupe Vanguard Code De Reprise Ageas SA/NV Portefeuille D'investissement
BRIEF published on 03/08/2024 at 16:41, 2 years 7 months ago The Vanguard Group, Inc. Reports Position in Ageas SA/NV The Vanguard Group Takeover Code Financial Disclosure Investment Portfolio Ageas SA/NV
PRESS RELEASE published on 03/08/2024 at 16:36, 2 years 7 months ago Form 8.3 - The Vanguard Group, Inc.: Ageas SA/NV The Vanguard Group, Inc. discloses a 3.44% stake in Ageas SA/NV through Form 8.3, with recent dealings in ordinary shares Ordinary Shares Form 8.3 The Vanguard Group Inc. Stake Disclosure Ageas SA/NV
BRIEF published on 03/07/2024 at 15:29, 2 years 7 months ago Participation accrue de Vanguard Group dans Ageas SA/NV Groupe D'avant-garde Code De Reprise Ageas SA/NV Divulgation Des Titres Opérations Financières
BRIEF published on 03/07/2024 at 15:29, 2 years 7 months ago Vanguard Group's Increased Stake in Ageas SA/NV Financial Transactions Takeover Code Securities Disclosure Vanguard Group Ageas SA/NV
PRESS RELEASE published on 03/07/2024 at 15:24, 2 years 7 months ago Form 8.3 - The Vanguard Group, Inc.: Ageas SA/NV The Vanguard Group, Inc. discloses 3.44% ownership in Ageas SA/NV. Dealings on 06 March 2024 include purchase and sale of ordinary securities Securities Dealings Ownership Disclosure Public Disclosure The Vanguard Group Inc Ageas SA/NV
BRIEF published on 03/06/2024 at 15:49, 2 years 7 months ago Vanguard Group annonce une participation dans Ageas SA/NV Marché Financier Groupe D'avant-garde Ageas SA/NV Divulgation Des Investissements Secteur Des Assurances
Published on 10/23/2026 at 16:00, 1 hour 33 minutes ago Leggett Dynamics's Mid-Class Massage System Wins Gasgoo's Best Technical Practice Award
Published on 10/23/2026 at 13:23, 4 hours 10 minutes ago Slam Mobilizes Drill Team to Moose Lake, Intersecting Broad Zones of Brecciated and Altered Rock With Visible Stibnite Along the Moose Lake Fault Zone
Published on 10/23/2026 at 13:00, 4 hours 33 minutes ago First Canadian Graphite Inc. Announces Flow-Through Financing
Published on 10/23/2026 at 13:00, 4 hours 33 minutes ago First Canadian Graphite Inc. annonce un financement accréditif
Published on 10/23/2026 at 02:20, 15 hours 13 minutes ago Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering
Published on 10/23/2026 at 17:11, 21 minutes ago Original-Research: Serviceware SE (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 10/23/2026 at 16:40, 52 minutes ago THE POWER OF WILL: A SERIES OF CONVERSATIONS ABOUT DETERMINATION AND INDIVIDUALITY
Published on 10/23/2026 at 16:25, 1 hour 7 minutes ago Lassa introduces new winter tyre Wintus 3 for light commercial vehicles
Published on 10/23/2026 at 07:00, 10 hours 33 minutes ago Safran publie son chiffre d’affaires du 3e trimestre 2026
Published on 10/22/2026 at 18:00, 23 hours 33 minutes ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 23 hours 33 minutes ago THERMADOR GROUPE : Fin du programme de rachat d’actions débuté en août
Published on 10/22/2026 at 18:00, 23 hours 33 minutes ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
